New EULAR points-to-consider can help identify people at risk of psoriatic arthritis

FHS
July 17, 2023
12:47 pm

The transition from psoriasis to PsA – and the early diagnosis of PsA – is of considerable scientific and clinical interest. People typically have psoriatic skin disease for a decade or more before they begin to experience the joint involvement of PsA.

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova

April 18, 2024

Another major pharma company departs BIO

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well. UCB, headquartered in

January 4, 2024

The USPSTF recommend clinicians refer children and adolescents 6 years or older with a high BMI to intensive behavioral interventions

Researchers at the USPSTF discussed the high prevalence of obesity among adolescents and children in the US, particularly among certain ethnic groups and those from

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.